Overview

Exparel Use in Peripheral Nerve Blocks and Local Infiltration for Foot and Ankle Surgery: A Randomized Controlled Trial

Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
Liposomal Bupivacaine (Exparel) has been recently studied as the active agent utilized in various nerve block. Due to its liposomal form allowing for extended delivery, Exparel has been used in various peri-operative nerve blocks among multiple orthopaedic specialties in hopes of achieving improved pain control and decreased opioid use. This study compares the efficacy and effect on opioid use of peripheral nerve blocks and local infiltration with and without Exparel in patients undergoing foot and ankle surgery.
Phase:
Phase 4
Details
Lead Sponsor:
St. Luke's Hospital, Pennsylvania
Treatments:
Bupivacaine